Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CT7/MAGE-A3/WT1 mRNA-electroporated LCs |
Trade Name | |
Synonyms | |
Drug Descriptions |
CT7/MAGE-A3/WT1 mRNA-electroporated LCs are autologous patient-derived Langerhans cells that are modifed to induce a cytotoxic T-cell response against cancer cells expressing MAGEC1 (CT7), MAGEA3, and WT1 (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C113174 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CT7/MAGE-A3/WT1 mRNA-electroporated LCs | CT7/MAGE-A3/WT1 mRNA-electroporated LCs | 0 | 1 |